Could a loss of alpha-synuclein function put dopaminergic neurons at risk?
- PMID: 15189334
- DOI: 10.1111/j.1471-4159.2004.02423.x
Could a loss of alpha-synuclein function put dopaminergic neurons at risk?
Abstract
The alpha-synuclein gene is implicated in Parkinson's disease, the symptoms of which occur after a marked loss of substantia nigra dopamine neurons. While the function of alpha-synuclein is not entirely elucidated, one function appears to be as a normal regulatory protein that can bind to and inhibit tyrosine hydroxylase, the rate-limiting enzyme in dopamine synthesis. Soluble alpha-synuclein levels may be diminished in Parkinson's disease substantia nigra dopamine neurons both by reduced expression and by alpha-synuclein aggregation as Lewy bodies and Lewy neurites form. The loss of functional alpha-synuclein may then result in dysregulation of tyrosine hydroxylase, dopamine transport and dopamine storage, resulting in excess cytosolic dopamine. Because dopamine and its metabolites are reactive molecules capable of generating highly reactive quinones and reactive oxygen species, a failure to package dopamine into vesicles could cause irreversible damage to cellular macromolecules and contribute to resultant neurotoxicity. This review focuses on how a loss of normal alpha-synuclein function may contribute to the dopamine-related loss of substantia nigra neurons during Parkinson's disease pathogenesis.
Similar articles
-
A Drosophila model of Parkinson's disease.Nature. 2000 Mar 23;404(6776):394-8. doi: 10.1038/35006074. Nature. 2000. PMID: 10746727
-
Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.J Neurochem. 2004 Oct;91(2):451-61. doi: 10.1111/j.1471-4159.2004.02728.x. J Neurochem. 2004. PMID: 15447678
-
alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10813-8. doi: 10.1073/pnas.152339799. Epub 2002 Jul 16. Proc Natl Acad Sci U S A. 2002. PMID: 12122208 Free PMC article.
-
Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse?FASEB J. 2004 Apr;18(6):637-47. doi: 10.1096/fj.03-1112rev. FASEB J. 2004. PMID: 15054086 Review.
-
Alpha-synuclein and Parkinson's disease.Cell Mol Life Sci. 2000 Dec;57(13-14):1894-908. doi: 10.1007/PL00000671. Cell Mol Life Sci. 2000. PMID: 11215516 Free PMC article. Review.
Cited by
-
"Janus-Faced" α-Synuclein: Role in Parkinson's Disease.Front Cell Dev Biol. 2021 May 28;9:673395. doi: 10.3389/fcell.2021.673395. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34124057 Free PMC article. Review.
-
Could α-Synuclein Modulation of Insulin and Dopamine Identify a Novel Link Between Parkinson's Disease and Diabetes as Well as Potential Therapies?Front Mol Neurosci. 2018 Dec 21;11:465. doi: 10.3389/fnmol.2018.00465. eCollection 2018. Front Mol Neurosci. 2018. PMID: 30622456 Free PMC article. Review.
-
FTY720/Fingolimod Reduces Synucleinopathy and Improves Gut Motility in A53T Mice: CONTRIBUTIONS OF PRO-BRAIN-DERIVED NEUROTROPHIC FACTOR (PRO-BDNF) AND MATURE BDNF.J Biol Chem. 2016 Sep 23;291(39):20811-21. doi: 10.1074/jbc.M116.744029. Epub 2016 Aug 15. J Biol Chem. 2016. PMID: 27528608 Free PMC article.
-
Synucleinopathy-associated pathogenesis in Parkinson's disease and the potential for brain-derived neurotrophic factor.NPJ Parkinsons Dis. 2021 Apr 12;7(1):35. doi: 10.1038/s41531-021-00179-6. NPJ Parkinsons Dis. 2021. PMID: 33846345 Free PMC article. Review.
-
Protein phosphatase 2A is involved in the tyrosine hydroxylase phosphorylation regulated by α-synuclein.Neurochem Res. 2015 Mar;40(3):428-37. doi: 10.1007/s11064-014-1477-x. Epub 2015 Jan 8. Neurochem Res. 2015. PMID: 25567480
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous
